Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency

NCT00911625 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.

NCT NCT00911625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00911625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Lead sponsor
Loyola University
Phase
Phase 4
Overall status
Completed
Start date
January 21, 2009
Completion date
June 30, 2011
Enrollment
114 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

renal insufficiency, type 2 diabetes